| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $4.9B | $4.2B | $3.6B | $3.4B | $0.8B | $0.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.2B | $0.4B | $0.2B | $0.4B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $7.54 | $3.25 | $5.87 | $3.57 | $6.55 | $2.12 | $1.38 | $0.77 |
| EPS (Diluted) | $7.49 | $3.23 | $5.84 | $3.54 | $6.50 | $2.10 | $1.36 | $0.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.2B | $13.5B | $11.8B | $10.8B | $10.5B | $9.7B | $8.8B | $8.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $11.5B | $10.4B | $8.8B | $8.3B | $7.5B | $6.9B | $6.6B | $6.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.6B | $3.1B | $3.0B | $2.5B | $3.0B | $2.7B | $2.2B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.1B | $0.8B | $0.8B | $0.8B | $0.6B | $0.5B | — |
| Investing Cash Flow | $-1.5B | $-0.9B | $-0.7B | $-0.7B | $-0.6B | $-0.7B | $-0.5B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | — | — |
| Financing Cash Flow | $0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $0.1B | $0.1B | — |